- Home
- HUBB vs BNTX Comparison
HUBB vs BNTX Comparison
Compare HUBB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- BNTX
- Stock Information
- Founded
- HUBB 1888
- BNTX 2008
- Country
- HUBB United States
- BNTX Germany
- Employees
- HUBB N/A
- BNTX N/A
- Industry
- HUBB Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUBB Technology
- BNTX Health Care
- Exchange
- HUBB Nasdaq
- BNTX Nasdaq
- Market Cap
- HUBB 23.2B
- BNTX 23.9B
- IPO Year
- HUBB N/A
- BNTX 2019
- Fundamental
- Price
- HUBB $432.32
- BNTX $113.90
- Analyst Decision
- HUBB Hold
- BNTX Strong Buy
- Analyst Count
- HUBB 8
- BNTX 15
- Target Price
- HUBB $472.13
- BNTX $143.50
- AVG Volume (30 Days)
- HUBB 363.5K
- BNTX 659.5K
- Earning Date
- HUBB 01-28-2025
- BNTX 11-04-2024
- Dividend Yield
- HUBB 1.22%
- BNTX N/A
- EPS Growth
- HUBB 8.35
- BNTX N/A
- EPS
- HUBB 13.89
- BNTX N/A
- Revenue
- HUBB $5,640,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- HUBB $8.17
- BNTX N/A
- Revenue Next Year
- HUBB $5.08
- BNTX N/A
- P/E Ratio
- HUBB $31.10
- BNTX N/A
- Revenue Growth
- HUBB 7.50
- BNTX N/A
- 52 Week Low
- HUBB $315.38
- BNTX $76.53
- 52 Week High
- HUBB $481.35
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- HUBB 40.02
- BNTX 48.71
- Support Level
- HUBB $418.82
- BNTX $109.52
- Resistance Level
- HUBB $433.13
- BNTX $115.34
- Average True Range (ATR)
- HUBB 9.83
- BNTX 4.24
- MACD
- HUBB -3.06
- BNTX -0.72
- Stochastic Oscillator
- HUBB 22.74
- BNTX 27.24
About HUBB Hubbell Inc
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.